Improving the pathway to correct treatment for patients with muscle-invasive bladder cancer: exploring the myths around the BladderPath trial
- PMID: 40227037
- DOI: 10.1111/bju.16728
Improving the pathway to correct treatment for patients with muscle-invasive bladder cancer: exploring the myths around the BladderPath trial
Keywords: BladderPath; delays; muscle‐invasive bladder cancer; pathway; treatment.
References
-
- Bryan RT, Liu W, Pirrie SJ et al. Randomized comparison of magnetic resonance imaging versus transurethral resection for staging new bladder cancers: results from the prospective BladderPath trial. J Clin Oncol 2025. https://doi.org/10.1200/JCO.23.0239
-
- Bryan RT, Liu W, Pirrie SJ et al. Comparing an imaging‐guided pathway with the standard pathway for staging muscle‐invasive bladder cancer: preliminary data from the BladderPath study. Eur Urol 2021; 80: 12–15
-
- Kamat AM, Frankel P. Rethinking the path to bladder cancer staging: can magnetic resonance imaging speed up time to receipt of therapy in patients with muscle‐invasive bladder cancer? J Clin Oncol 2025. https://doi.org/10.1200/JCO-24-02482
-
- Russell B, Liedberg F, Khan MS et al. A systematic review and meta‐analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. Eur Urol Oncol 2020; 3: 239–249
-
- Chu AT, Holt SK, Wright JL et al. Delays in radical cystectomy for muscle‐invasive bladder cancer. Cancer 2019; 125: 2011–2017
Grants and funding
LinkOut - more resources
Full Text Sources
